Company: BIAF
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023405
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 0
---
bioAffinity
Technologies, Inc.

Condensed
Consolidated Balance Sheets

    September 30,
                                                                                2025  
    December 31,
                                                                                2024 

     (unaudited)  

    ASSETS 

    Current assets: 

    Cash and cash equivalents 
    $7,669,195  
    $1,105,291 
  
    Accounts and other receivables, net 
     448,990  
     1,139,204 
  
    Inventory 
     35,234  
     27,608 
  
    Prepaid expenses and other current assets 
     460,187  
     422,995 
  
    Total current assets 
     8,613,606  
     2,695,098 

    Non-current assets: 

    Property and equipment, net 
     303,122  
     375,385 
  
    Operating lease right-of-use asset, net 
     367,398  
     463,011 
  
    Finance lease right-of-use asset, net 
     113,553  
     780,872 
  
    Goodwill 
     1,404,486  
     1,404,486 
  
    Intangible assets, net 
     731,389  
     775,139 
  
    Other assets 
     12,815  
     19,676 

    Total assets 
    $11,546,369  
    $6,513,667 

    LIABILITIES AND STOCKHOLDERS’ EQUITY 

    Current liabilities: 

    Accounts payable 
    $940,761  
    $987,311 
  
    Accrued expenses 
     984,547  
     1,398,722 
  
    Unearned revenue 
     37,915  
     24,404 
  
    Operating lease liability, current portion 
     136,197  
     127,498 
  
    Finance lease liability, current portion 
     123,757  
     395,301 
  
    Notes payable, current portion 
     136,396  
     171,669 
  
    Total current liabilities 
     2,359,573  
     3,104,905 

    Non-current liabilities: 

    Operating lease liability, net